Insulet Corp (STU:GOV)
€ 228.1 5 (2.24%) Market Cap: 17.41 Bil Enterprise Value: 17.87 Bil PE Ratio: 45.89 PB Ratio: 16.81 GF Score: 93/100

Insulet Corp at Wells Fargo Healthcare Conference Transcript

Sep 07, 2023 / 01:30PM GMT
Release Date Price: €177.95 (-1.03%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

Good morning. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with the management team from Insulet. With us, we have: Jim Hollingshead, the CEO; Wayde McMillan, the CFO; and Trang Ly, Senior Vice President and Medical Director; also in the audience, Deb Gordon, Investor Relations.

So in terms of format, it's going to be a fireside chat. If anybody has a question, please raise your hand, we'll come around with a mic. Jim, Wayde and Trang, thanks so much for being here.

James R. Hollingshead
Insulet Corporation - President, CEO & Director

Great to be here, Larry. Thank you.

Questions & Answers

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

So let's start with the GLP-1s. The updates on GLP-1s are more and more positive each day, it seems. So Jim, can

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot